Skip to content

A Multicenter Randomized Controlled Trial of Catgut Implantation at Acupoints for the Treatment of Simple Obesity

Research on Health Care Technology and Products of Traditional Chinese Medicine (one)-Application and Scientific Evaluation of the Intervention of Obesity in Chinese Medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008384
Enrollment
Unknown
Registered
2016-04-24
Start date
2016-06-01
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

simple obesity

Interventions

Intervention group(Real catgut implantation at acupoints group):catgut implantation at acupoints and lifestyle intervention.
control group (sham catgut implantation at acupoints group): sham catgut implantation intervention and lifestyle modification.

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) meeting the diagnosis standard for simple obesity in Redefinition and Processing of Obesity in Asia & Pacific Area released by WHO in February 2000; (2) aged 18-45; (3) body mass index (BMI): BMI between 25 to 30; (4) waistline: male>=95cm; female>=85cm; (5) in case of smokers, they do not change their smoking habit for at least 2 months; (6) those who are willing to accept the above intervention methods.

Exclusion criteria

Exclusion criteria: (1) with endocrine disease (such as polycystic ovarian syndrome, Cushing's Disease, hypothyroidism, etc.); (2) with gestational diabetes; hypertension is not under control (SBP>=160mmHg; DBP>=100mmHg)or with disease in lung, heart, liver or kidney; (3) with nerve system disease or mental disorder, with hospitalized depression history, with more than twice paralepsy or suicidal tendency; (4) with history of being clinically diagnosed as eating disorder,such as bulimia cynorexia, anorexia, etc.; weight changes beyond 5kg in the last 3 months; (5) with history of losing weight by operation [27], with history of after-operation adhesion; (6) having taken drug with known influence on weight or appetite in the last 3 months, such as diet pill, corticosteroid drugs, anti-depression drugs, diazepam drugs, nonselective body antihistamine, nicotine replacement, hypoglycemic drugs; or with plan of giving up smoking and drinking; (7) female in pregnancy, lactation or climacteric; female planning to get pregnant in 40 weeks; (8) those who have receive catgut implantation at acupoints; (9) those who participated in clinical research on obesity in the last 3 months(10) those who have protein allergy and scar; (11) with skin disease, such as eczema and psoriasis, etc; (12) with coagulation disorder, or taking warfarin, heparin and other anticoagulant drugs; (13) those who are not cooperative or cannot hold on during treatment period.

Design outcomes

Primary

MeasureTime frame
waist circumference;

Secondary

MeasureTime frame
weight;body mass index;hip circumference;waist–hip ratio;percentage of body fat;IWQOL - Lite scale;SF - 36 life quality scale ;HAD scale;self-esteem scale;

Countries

China

Contacts

Public ContactZhou Zhong-yu

Hubei Provincial Hospital of Traditional Chinese Medicine

2209447940@qq.com+86 18672308659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026